Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: Functional and therapeutic implications

Behavioural Pharmacology

Volumn 23, Issue 5-6, 2012, Pages 516-525

  Ganella, Despina E ^a,b   Ryan, Philip J ^a,b   Bathgate, Ross A D ^a,b,c   Gundlach, Andrew L ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Department of Biochemistry and Molecular Biology ^*  (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adeno associated virus; arcuate nucleus; arousal; corticotropin releasing factor; motivation reward; nucleus incertus; oxytocin; paraventricular and supraoptic nuclei; periaqueductal grey; stress

Indexed keywords

ALPHA INTERMEDIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; LEPTIN; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE HORMONE ANTAGONIST; PROTEIN KINASE C; RELAXIN 3; RELAXIN 3 ANTAGONIST; SERELAXIN; UNCLASSIFIED DRUG;

ANOREXIA; CELL POPULATION; CELL STRAIN HEK293; CHO CELL; DIET RESTRICTION; DRUG CROSS REACTIVITY; EATING DISORDER; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FLUID INTAKE; FOOD INTAKE; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; IN SITU HYBRIDIZATION; LATERAL HYPOTHALAMUS; NERVE CELL NETWORK; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; RAT; REVIEW; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ANIMALS; APPETITE STIMULANTS; BEHAVIOR, ANIMAL; EATING DISORDERS; ENERGY METABOLISM; FEEDING BEHAVIOR; INJECTIONS, INTRAVENTRICULAR; LIGANDS; MICE; MOLECULAR TARGETED THERAPY; NERVE TISSUE PROTEINS; NEURONS; ORGAN SPECIFICITY; PEPTIDES; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RECOMBINANT PROTEINS; RELAXIN; SYNAPTIC TRANSMISSION; WEIGHT GAIN;

EID: 84864868683     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283576999     Document Type: Review

References (93)

1. Adamantidis A, de Lecea L (2008). Physiological arousal: a role for hypothalamic systems. Cell Mol Life Sci 65:1475-1488.
2. Aponte Y, Atasoy D, Sternson SM (2011). AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat Neurosci 14:351-355.
3. Banerjee A, Shen PJ, Ma S, Bathgate RAD, Gundlach AL (2010). Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology 58:145-155.
4. Bathgate RAD, Samuel CS, Burazin TCD, Layfield S, Claasz AA, Reytomas IGT, et al. (2002). Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene: novel members of the relaxin peptide family. J Biol Chem 277:1148-1157.
5. Bathgate RAD, Ivell R, Sanborn BM, Sherwood OD, Summers RJ (2006a). International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58:7-31.
6. Bathgate RAD, Lin F, Hanson NF, Otvos L, Guidolin A, Giannakis C, et al. (2006b). Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 45:1043-1053.
7. Beck B (2000). Neuropeptides and obesity. Nutrition 16:916-923.
8. Blasiak A, Blasiak T, Hossain MA, Wade JD, Gundlach AL (2009). Relaxin-3 innervation and modulation of the intergeniculate leaflet of the rat thalamus. Neuropeptides 43:430.
9. Blasiak A, Gundlach AL, Lewandowski MH (2010). Orexins increase nucleus incertus neuronal activity: implications for a possibly reinforcing arousal drive. FENS Abstracts 5, 104.2.
10. Blevins JE, Schwartz MW, Baskin DG (2004). Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am J Physiol Regul Integr Comp Physiol 287:R87-R96.
11. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T (1998). The neuropeptide Y agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95:15043-15048.
12. Burazin TCD, Bathgate RAD, Macris M, Layfield S, Gundlach AL, Tregear GW (2002). Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J Neurochem 82:1553-1557.
13. Butler AA, Cone RD (2002). The melanocortin receptors: lessons from knockout models. Neuropeptides 36:77-84.
14. Callander GE, Bathgate RAD (2010). Relaxin family peptide systems and the central nervous system. Cell Mol Life Sci 67:2327-2341.
15. Carlin KM, Vale WW, Bale TL (2006). Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. Proc Natl Acad Sci USA 103:3462-3467.
16. Chen J, Kuei C, Sutton SW, Bonaventure P, Nepomuceno D, Eriste E, et al. (2005). Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian species. J Pharmacol Exp Ther 312:83-95.
17. Choi DL, Davis JF, Fitzgerald ME, Benoit SC (2010). The role of orexin-A in food motivation, reward-based feeding behavior and food-induced neuronal activation in rats. Neuroscience 167:11-20.
18. Cowley MA, Smart JL, Rubinstein M, Cordan MG, Diano S, Horvath TL, et al. (2001). Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480-484.
19. Currie PJ, Mirza A, Fuld R, Park D, Vasselli JR (2005). Ghrelin is an orexigenic and metabolic signaling peptide in the arcuate and paraventricular nuclei. Am J Physiol Regul Integr Comp Physiol 289:R353-R358.
20. De Backer MWA, la Fleur SE, Brans MAD, van Rozen AJ, Luijendijk MCM, Merkestein M, et al. (2011). Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions. Int J Obesity 35:629-641.
21. Dietrich MO, Horvath TL (2009). Feeding signals and brain circuitry. Eur J Neurosci 30:1688-1696.
22. Donizetti A, Grossi M, Pariante P, D'Aniello E, Izzo G, Minucci S, Aniello F (2008). Two neuron clusters in the stem of postembryonic zebrafish brain specifically express relaxin-3 gene: first evidence of nucleus incertus in fish. Dev Dyn 237:3864-3869.
23. Douglas AJ, Johnstone LE, Leng G (2007). Neuroendocrine mechanisms of change in food intake during pregnancy: a potential role for brain oxytocin. Physiol Behav 91:352-365.
24. Faouzi M, Leshan R, Bjornholm M, Hennessey T, Jones J, Munzberg H (2007). Differential accessibility of circulating leptin to individual hypothalamic sites. Endocrinology 148:5414-5423.
25. Gaetani S, Fu J, Cassano T, Dipasquale P, Romano A, Righetti L, et al. (2010). The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J Neurosci 30:8096-8101.
26. Ganella DE, Callander GE, Ma S, McCown TJ, Gundlach AL, Bathgate RAD (2010). Gene transfer strategy for the delivery of relaxin-3 agonists and antagonists into the rat brain. Rouen, France: 7th Int Congr Neuroendocrinol; P1-156.
27. Gao Q, Horvath TL (2007). Neurobiology of feeding and energy expenditure. Annu Rev Neurosci 30:367-398.
28. Garza JC, Kim CS, Liu J, Zhang W, Lu XY (2008). Adeno-associated virusmediated knockdown of melanocortin-4 receptor in the paraventricular nucleus of the hypothalamus promotes high-fat diet-induced hyperphagia and obesity. J Endocrinol 197:471-482.
29. Goto M, Swanson LW, Canteras NS (2001). Connections of the nucleus incertus. J Comp Neurol 438:86-122.
30. Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T, et al. (2005). Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci 8:1289-1291.
31. Halls ML, Bathgate RAD, Summers RJ (2006). Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms. Mol Pharmacol 70:214-226.
32. Haslam DW, James WPT (2005). Obesity. Lancet 366:1197-1209.
33. Hassani OK, Henny P, Lee MG, Jones BE (2010). GABAergic neurons intermingled with orexin and MCH neurons in the lateral hypothalamus discharge maximally during sleep. Eur J Neurosci 32:448-457.
34. Haugaard-Jonsson LM, Hossain MA, Daly NL, Bathgate RAD,Wade JD, Craik DJ, Rosengren KJ (2008). Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist. J BiolChem283:23811-23818.
35. Haugaard-Kedstrom LM, Shabanpoor F, Hossain MA, Clark RJ, Ryan PJ, Craik DJ, et al. (2011). Design, synthesis, and characterization of a single-chain peptide antagonist for the Relaxin-3 Receptor RXFP3. J AmChemSoc 133:4965-4974.
36. Hida T, Takahashi E, Shikata K, Hirohashi T, Sawai T, Seiki T, et al. (2006). Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J Recept Signal Transduct Res 26:147-158.
37. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJW (2002). Activation of orphan receptors by the hormone relaxin. Science 295:671-674.
38. Jones BE (2005). From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 26:578-586.
39. Kalra SP, Dube MG, Pu SY, Xu B, Horvath TL, Kalra PS (1999). Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Rev 20:68-100.
40. Kenny PJ (2011). Reward mechanisms in obesity: new insights and future directions. Neuron 69:664-679.
41. Kirkham TC,Williams CM, Fezza F, Di Marzo V (2002). Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550-557.
42. Kokkotou E, Jeon JY, Wang XM, Marino FE, Carlson M, Trombly DJ, Maratos-Flier E (2005). Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms. Am J Physiol Regul Integr Comp Physiol 289:R117-R124.
43. Korner J, Savontaus E, Chua SC, Leibel RL, Wardlaw SL (2001). Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus. J Neuroendocrinol 13:959-966.
44. Krashes MJ, Koda S, Ye CP, Rogan SC, Adarns AC, Cusher DS, et al. (2011). Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J Clin Invest 121:1424-1428.
45. Kuei C, Sutton S, Bonaventure P, Pudiak C, Shelton J, Zhu J, et al. (2007). R3(BD23-27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization. J Biol Chem 282:25425-25435.
46. Leibowitz SF (2005). Regulation and effects of hypothalamic galanin: relation to dietary fat, alcohol ingestion, circulating lipids and energy homeostasis. Neuropeptides 39:327-332.
47. Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, et al. (2003). Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J Biol Chem 278:50754-50764.
48. Liu C, Chen J, Kuei C, Sutton S, Nepomuceno D, Bonaventure P, Lovenberg TW (2005). Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol Pharmacol 67:231-240.
49. Lutter M, Nestler EJ (2009). Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr 139:629-632.
50. Ma S, Shen PJ, Burazin TCD, Tregear GW, Gundlach AL (2006). Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: Restricted somatic co-expression a clue to relaxin action? Neuroscience 141:329-344.
51. Ma S, Bonaventure P, Ferraro T, Shen PJ, Burazin TCD, Bathgate RAD, et al. (2007). Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat. Neuroscience 144:165-190.
52. Ma S, Olucha-Bordonau FE, Hossain MA, Lin F, Kuei C, Liu C, et al. (2009a). Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learn Mem 16:730-742.
53. Ma S, Sang Q, Lanciego JL, Gundlach AL (2009b). Localization of relaxin-3 in brain of Macaca fascicularis: identification of a nucleus incertus in primate. J Comp Neurol 517:856-872.
54. McCown TJ (2006). Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther 14:63-68.
55. McGowan BM, Stanley SA, Smith KL, White NE, Connolly MM, Thompson EL, et al. (2005). Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146:3295-3300.
56. McGowan BM, Stanley SA, Smith KL, Minnion JS, Donovan J, Thompson EL, et al. (2006). Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept 136:72-77.
57. McGowan BM, Stanley SA,White NE, Spangeus A, Patterson M, Thompson EL, et al. (2007). Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. Am J Physiol Endocrinol Metab 292:E913-E919.
58. McGowan BM, Stanley SA, Ghatei MA, Bloom SR (2009). Relaxin-3 and its role in neuroendocrine function. Ann NY Acad Sci 1160:250-255.
59. McGowan BMC, Minnion JS, Murphy KG, White NE, Roy D, Stanley SA, et al. (2010). Central and peripheral administration of human relaxin-2 to adult male rats inhibits food intake. Diabetes Obes Metab 12:1090-1096.
60. Meister B, Hakansson ML (2001). Leptin receptors in hypothalamus and circumventricular organs. Clin Exp Pharmacol Physiol 28:610-617.
61. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006). Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555.
62. Olson BR, Drutarosky MD, Chow MS, Hruby VJ, Stricker EM, Verbalis JG (1991). Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides 12:113-118.
63. Olucha-Bordonau FE, Otero-Garcia M, Sanchez-Perez AM, Nunez A, Ma S, Gundlach AL (2012). Distribution and targets of the relaxin-3 innervation of the septal area in the rat. J Comp Neurol 520:1903-1939.
64. Otsubo H, Onaka T, Suzuki H, Katoh A, Ohbuchi T, Todoroki M, et al. (2010). Centrally administered relaxin-3 induces Fos expression in the osmosensitive areas in rat brain and facilitates water intake. Peptides 31:1124-1130.
65. Parker JA, Bloom SR (2012). Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology 63:18-30.
66. Pfaff D, Ribeiro A, Matthews J, Kow LM (2008). Concepts and mechanisms of generalized central nervous system arousal. Ann NY Acad Sci 1129:11-25.
67. Qian S, Chen H,Weingarth D, Trumbauer ME, Novi DE, Guan XM, et al. (2002). Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22: 5027-5035.
68. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585.
69. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000). Central nervous system control of food intake. Nature 404:661-671.
70. Shabanpoor F, Hossain MA, Ryan PJ, Belgi A, Layfield S, Kocan M, et al. (2012). Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1. J Med Chem 55:1671-1681.
71. Shoblock JR, Welty N, Dugovic C, Sutton S, Bonaventure P, Lovenberg TW (2010). Endogenous relaxin-3 is necessary for positive mood in mice. Int J Neuropsychopharmacol 13:67.
72. Smith CM, Lawrence AJ, Sutton SW, Gundlach AL (2009). Behavioral phenotyping of mixed background (129S5:B6) relaxin-3 knockout mice. Ann NY Acad Sci 1160:236-241.
73. Smith CM, Shen PJ, Banerjee A, Bonaventure P, Ma S, Bathgate RAD, et al. (2010). Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J Comp Neurol 518:4016-4045.
74. Smith CM, Ryan PJ, Hosken IT, Ma S, Gundlach AL (2011). Relaxin-3 systems in the brain-the first 10 years. J Chem Neuroanat 42:262-275.
75. Smith CM, Hosken IT, Sutton SW, Lawrence AJ, Gundlach AL (2012). Relaxin-3 null mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav 11:94-104.
76. South T,Westbrook F, Morris MJ (2012). Neurological and stress related effects of shifting obese rats from a palatable diet to chow and lean rats from chow to a palatable diet. Physiol Behav 105:1052-1057.
77. Stanley BG, Daniel DR, Chin AS, Leibowitz SF (1985). Paraventricular nucleus injections of peptide-YY and neuropeptide-Y preferentially enhance carbohydrate ingestion. Peptides 6:1205-1211.
78. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RAD, Hsueh AJW (2003). H3 Relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem 278:7855-7862.
79. Summerlee AJS, Hornsby DJ, Ramsey DG (1998). The dipsogenic effects of rat relaxin: the effect of photoperiod and the potential role of relaxin on drinking in pregnancy. Endocrinology 139:2322-2328.
80. Sunn N, Egli M, Burazin TCD, Burns P, Colvill L, Davern P, et al. (2002). Circulating relaxin acts on subfornical organ neurons to stimulate water drinking in the rat. Proc Natl Acad Sci USA 99:1701-1706.
81. Sutton SW, Bonaventure P, Kuei C, Roland B, Chen J, Nepomuceno D, et al. (2004). Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Neuroendocrinology 80:298-307.
82. Sutton SW, Shelton J, Smith CM, Williams J, Yun S, Motley T, et al. (2009). Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system. Ann NY Acad Sci 1160:242-249.
83. Tanaka M, Iijima N, Miyamoto Y, Fukusumi S, Itoh Y, Ozawa H, Ibata Y (2005). Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur J Neurosci 21:1659-1670.
84. Tiesjema B, Adan RA, Luijendijk MC, Kalsbeek A, la Fleur SE (2007). Differential effects of recombinant adeno-associated virus-mediated neuropeptide Y overexpression in the hypothalamic paraventricular nucleus and lateral hypothalamus on feeding behavior. J Neurosci 27:14139-14146.
85. Van derWesthuizen ET,Werry TD, Sexton PM, Summers RJ (2007). The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism. Mol Pharmacol 71:1618-1629.
86. Watanabe Y, Miyamoto Y, Matsuda T, Tanaka M (2010). Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus. J Mol Neurosci 43:169-174.
87. Watanabe Y, Tsujimura A, Takao K, Nishi K, Ito Y, Yasuhara Y, et al. (2011). Relaxin-3-deficient mice showed slight alteration in anxiety-related behavior. Front Behav Neurosci 5:50.
88. Wilkinson T, Speed T, Tregear G, Bathgate R (2005). Evolution of the relaxin-like peptide family. BMC Evol Biol 5:14-31.
89. Williams KW, Elmquist JK (2011). Lighting up the hypothalamus: coordinated control of feeding behavior. Nat Neurosci 14:277-278.
90. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M (2001). To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24:429-458.
91. Wirth MM, Giraudo SQ (2000). Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding. Peptides 21:1369-1375.
92. Wu Q, Palmiter RD (2011). GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism. Eur J Pharmacol 660:21-27.
93. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U (1999). Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nature Med 5:1066-1070.